Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
暂无分享,去创建一个
M. Ohira | T. Morisaki | S. Noda | S. Kashiwagi | N. Onoda | Y. Asano | T. Takashima | S. Ishihara | Yukie Tauchi | Sae Ishihara